--- title: "Daily Hong Kong Stock Market News Briefing (March 21, Friday)" type: "News" locale: "en" url: "https://longbridge.com/en/news/232657952.md" description: "Daily Hong Kong Stock Market News Summary (Friday, March 21) includes: 1. China Mobile expects operating revenue of RMB 104.08 billion in 2024, a year-on-year increase of 3.1%; profit attributable to shareholders is expected to be RMB 13.84 billion, a year-on-year increase of 5.0%. 2. Henderson Land's basic profit attributable to shareholders for 2024 is expected to be HKD 9.774 billion, a year-on-year increase of 1%. 3. GOGOX expects a loss of between RMB 170 million and 220 million in 2024, a reduction of approximately 80% to 84.5%. 4. CK Asset's revenue for the 2024 fiscal year is expected to be HKD 45.529 billion, with profit attributable to shareholders of HKD 13.657 billion. 5. TUHU expects revenue of RMB 14.8 billion in 2024, a year-on-year increase of 8.5%. 6. CK Hutchison's revenue for the 2024 fiscal year is expected to be HKD 476.682 billion, with a proposed dividend of HKD 1.514 per share. 7. SINO BIOPHARM expects revenue of RMB 28.87 billion in 2024, with a net profit of RMB 3.5 billion. 8. QINGDAO PORT expects total operating revenue of RMB 18.941 billion in 2024, with a net profit of approximately RMB 5.235 billion. 9. Tongcheng Travel expects revenue of RMB 17.341 billion in the 2024 fiscal year, with a net profit of RMB 1.974 billion" datetime: "2025-03-21T01:05:02.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/232657952.md) - [en](https://longbridge.com/en/news/232657952.md) - [zh-HK](https://longbridge.com/zh-HK/news/232657952.md) generator: "portal-rs" --- # Daily Hong Kong Stock Market News Briefing (March 21, Friday) Individual Stock News 1. China Mobile (00941.HK): The operating revenue for 2024 is expected to be RMB 104.08 billion, a year-on-year increase of 3.1%; profit attributable to shareholders is expected to be RMB 13.84 billion, a year-on-year increase of 5.0%. 2. Henderson Land (00012.HK): The group's basic profit attributable to shareholders for 2024 is expected to be HKD 9.774 billion, a year-on-year increase of 1%. 3. GOGOX (02246.HK): The group expects a loss attributable to equity holders for 2024 to be between approximately RMB 170 million and RMB 220 million, a decrease of approximately 80.0% to 84.5%. 4. CK Asset (01113.HK): The group's revenue for the fiscal year 2024 is expected to be HKD 45.529 billion, compared to HKD 47.243 billion for the fiscal year 2023. The profit attributable to shareholders for fiscal year 2024 is expected to be HKD 13.657 billion, compared to HKD 17.340 billion for fiscal year 2023. 5. Tuhu (09690.HK) announced its 2024 performance, with annual revenue of HKD 14.8 billion, a year-on-year increase of 8.5%. 6. CK Hutchison (00001.HK): The total revenue for the fiscal year 2024 is expected to be HKD 476.682 billion, compared to HKD 461.558 billion for the fiscal year 2023. A final dividend of HKD 1.514 per share is proposed. 7. SINO BIOPHARM (01177.HK): Revenue for 2024 is expected to be RMB 28.87 billion, a year-on-year increase of 10.2%; net profit is expected to be RMB 3.5 billion, a year-on-year increase of 50.1%. Revenue from new products launched within the last five years reached RMB 10.09 billion, a year-on-year increase of 25.4%. 8. QDPI (06198.HK): Total operating revenue for 2024 is expected to be HKD 18.941 billion, a year-on-year increase of 4.23%; net profit is approximately HKD 5.235 billion, a year-on-year increase of 6.33%. 9. Tongcheng Travel (00780.HK): Revenue for the fiscal year 2024 is expected to be HKD 17.341 billion, a year-on-year increase of 45.8%; net profit is expected to be HKD 1.974 billion, a year-on-year increase of 27.04%. The number of annual paying users increased by 1.5% year-on-year, reaching 238 million ### Related Stocks - [601298.CN](https://longbridge.com/en/quote/601298.CN.md) - [06198.HK](https://longbridge.com/en/quote/06198.HK.md) - [01177.HK](https://longbridge.com/en/quote/01177.HK.md) - [01113.HK](https://longbridge.com/en/quote/01113.HK.md) - [00012.HK](https://longbridge.com/en/quote/00012.HK.md) - [02246.HK](https://longbridge.com/en/quote/02246.HK.md) - [09690.HK](https://longbridge.com/en/quote/09690.HK.md) - [00780.HK](https://longbridge.com/en/quote/00780.HK.md) - [00941.HK](https://longbridge.com/en/quote/00941.HK.md) - [00001.HK](https://longbridge.com/en/quote/00001.HK.md) ## Related News & Research - [Henderson Land Development (SEHK:12) Could Be 62% Overvalued As Chester II Demand Lifts Sentiment](https://longbridge.com/en/news/298186906.md) - [Sino Biopharma reports Phase I data showing TQC3721 dry powder inhaler boosts COPD lung function in dose-ranging trial](https://longbridge.com/en/news/298202928.md) - [Sino Biopharm presents ERS 2026 preclinical data for oral STAT6 degrader TQH5528](https://longbridge.com/en/news/298295965.md) - [Sino Biopharm says FDA clears IND for TQB6426 GPC3 ADC trial in advanced tumors](https://longbridge.com/en/news/297915540.md) - [Evergrande NEV reschedules board meeting to approve delayed 2024-25 results](https://longbridge.com/en/news/298337764.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**